Aurora Cannabis Inc(ACB)
USD --+0.00%
Reward61Moderate
Risk53Moderate
📊75%Data
Thin -23% profit margin
ACB
+0.0 · +0.00%
USD · NASDAQ
Aurora Cannabis Inc | Healthcare
Turnaround Story
Market Cap:205.76M
ℹ️
Reward Rating
61
Moderate
Top 50% (model universe)
75% data coverage
ℹ️
Risk Rating
53
Moderate
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on ACB to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

Analyst Target

Analyst consensus price target: C$6.42.

What is Aurora Cannabis Inc?

, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally.

ACB · Verdict

Solid reward · elevated risk

ACB stands out on balance sheet and growth, but watch the cash flow signal.

Based on 88% data coverage

ACB · Verdict

What’s working & what to watch

Strengths 3

  • Balance sheet79/100

    Interest covered 3.4×

  • Growth74/100

    Revenue +15.8% CAGR

  • Valuation73/100

    P/E 19.2×

Watchouts 3

  • Cash flow24/100

    -1% free-cash-flow margin

  • Volatility35/100

    Below average

  • Profitability41/100

    0% net margin · -16% ROE

Model-based scoring. For information only — not financial advice.

What is Aurora Cannabis Inc?

, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally. It operates through two segments, Canadian Cannabis and Plant Propagation. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 205.76M.

Financial Highlights

Investment Breakdown

📈 Growth
Revenue and earnings growing steadily, indicating improving operating performance.
💰 Profitability
Profitability metrics are mixed — margins may be under pressure.
⚠️ Risk
Risk profile appears balanced versus broad market conditions.
💸 Valuation
Valuation is less clear with a negative earnings base.

OpenBook Logo Analysis

Reward: Moderate (61)

The scoring profile indicates moderate reward potential, with growth and valuation as the leading contributors. Risk indicators are elevated — volatility and macro sensitivity warrant consideration.

For informational purposes only. Not financial advice.

Company Information
SectorHealthcare
Market Cap205.76M
P/E RatioN/A
Dividend YieldN/A
52 Week High6.665
52 Week Low3.07
Last AnnualMarch
IPO Date7/11/2014
IncorporatedUSA
Shares Outstanding59M
No. of EmployeesN/A
IndustryDrug Manufacturers - Specialty & Generic
ExchangeNASDAQ
Beta1.32
CurrencyUSD · Reports in CAD